Updates

News from CinPressa

Follow CinPressa's progress as CIN-111 advances through development.

  1. Sample

    Placeholder headline of about this length, long enough to show how a real wire headline wraps across this column

    The summary sits here and runs to roughly two lines at this measure, which is about what a release abstract needs. Replace this array with real entries in the file above.

    Read the release

Let’s advance medicine, together.

Stay connected with CinPressa

For partnering, investment, or general inquiries, connect with the team through our Contact page.

CinPressapharma

Advancing a best-in-class, long-acting AGT siRNA (CIN-111) for a durable backbone of blood pressure control.

Parent company

© 2026 CinPressa Pharma. All rights reserved.

A CinRx Pharma portfolio company